Alok Khorana, MD of Cleveland Clinic, discusses how recent funding for thromboprophylaxis may lead to a clinical trial that will hopefully better cancer research for the future at the 58th ASH Annual Meeting in San Diego, CA.
Recent Funding for Thromboprophylaxis Study
